These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

722 related items for PubMed ID: 7946395

  • 1. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.
    Voelkel NF, Tuder RM, Bridges J, Arend WP.
    Am J Respir Cell Mol Biol; 1994 Dec; 11(6):664-75. PubMed ID: 7946395
    [Abstract] [Full Text] [Related]

  • 2. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS, Kim DH, Lee YJ, Lee SE, Kang WJ, Chang HJ, Shin JS.
    Respir Res; 2014 Nov 25; 15():148. PubMed ID: 25420924
    [Abstract] [Full Text] [Related]

  • 3. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP, Zhang X, Jackson EK, Dacic S, Petrusevska G.
    Vascul Pharmacol; 2006 Dec 25; 45(6):358-67. PubMed ID: 16872912
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-1 receptor antagonist inhibits pulmonary hypertension induced by inflammation.
    Voelkel NF, Tuder R.
    Ann N Y Acad Sci; 1994 May 28; 725():104-9. PubMed ID: 8030981
    [No Abstract] [Full Text] [Related]

  • 5. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
    Hill NS, Warburton RR, Pietras L, Klinger JR.
    J Appl Physiol (1985); 1997 Oct 28; 83(4):1209-15. PubMed ID: 9338430
    [Abstract] [Full Text] [Related]

  • 6. Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.
    Tofovic SP, Salah EM, Mady HH, Jackson EK, Melhem MF.
    J Cardiovasc Pharmacol; 2005 Oct 28; 46(4):430-7. PubMed ID: 16160593
    [Abstract] [Full Text] [Related]

  • 7. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
    Zhuang W, Lian G, Huang B, Du A, Xiao G, Gong J, Xu C, Wang H, Xie L.
    Exp Biol Med (Maywood); 2018 Aug 28; 243(12):995-1003. PubMed ID: 30099957
    [Abstract] [Full Text] [Related]

  • 8. PAF antagonists inhibit monocrotaline-induced lung injury and pulmonary hypertension.
    Ono S, Voelkel NF.
    J Appl Physiol (1985); 1991 Dec 28; 71(6):2483-92. PubMed ID: 1838107
    [Abstract] [Full Text] [Related]

  • 9. Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension.
    Partovian C, Adnot S, Eddahibi S, Teiger E, Levame M, Dreyfus P, Raffestin B, Frelin C.
    Am J Physiol; 1998 Dec 28; 275(6):H1948-56. PubMed ID: 9843792
    [Abstract] [Full Text] [Related]

  • 10. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S, de Visser YP, Steendijk P, Schutte CI, Laghmani el H, Wagenaar GT, Bax WH, Mantikou E, Pijnappels DA, Atsma DE, Schalij MJ, van der Wall EE, van der Laarse A.
    Am J Physiol Heart Circ Physiol; 2009 Nov 28; 297(5):H1606-16. PubMed ID: 19783775
    [Abstract] [Full Text] [Related]

  • 11. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
    Porvasnik SL, Germain S, Embury J, Gannon KS, Jacques V, Murray J, Byrne BJ, Shacham S, Al-Mousily F.
    J Pharmacol Exp Ther; 2010 Aug 28; 334(2):364-72. PubMed ID: 20430844
    [Abstract] [Full Text] [Related]

  • 12. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X, Yang Y, Yang D, Tong G, Lv S, Lin X, Chen C, Dong W.
    J Vasc Surg; 2016 Nov 28; 64(5):1468-1477. PubMed ID: 26527422
    [Abstract] [Full Text] [Related]

  • 13. [Tanshinone IIA sulfonate upregulated pulmonary artery smooth muscle peroxisome proliferator-activated receptor γ expression in monocrotaline induced pulmonary hypertension rat].
    Jiang Q, Chen Y, Chen X, Zhang J, Lu W, Wang J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 May 28; 37(5):360-4. PubMed ID: 25011512
    [Abstract] [Full Text] [Related]

  • 14. [Lung 3H-thymidine incorporation in monocrotaline (MCT)-treated rats--role of platelet-activating factor (PAF)].
    Ono S, Tanita T, Ashino Y, Noda M, Tabata S, Hoshikawa Y, Ueda S, Nishimura T, Fujimura S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 May 28; 32(5):441-5. PubMed ID: 8084100
    [Abstract] [Full Text] [Related]

  • 15. Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats.
    Horstman DJ, Frank DU, Rich GF.
    Anesth Analg; 1998 Jan 28; 86(1):74-81. PubMed ID: 9428855
    [Abstract] [Full Text] [Related]

  • 16. Pulmonary hypertension is ameliorated in mice deficient in thrombin-activatable fibrinolysis inhibitor.
    Qin L, D'Alessandro-Gabazza CN, Aoki S, Gil-Bernabe P, Yano Y, Takagi T, Boveda-Ruiz D, Ramirez Marmol AY, San Martin Montenegro VT, Toda M, Miyake Y, Taguchi O, Takei Y, Morser J, Gabazza EC.
    J Thromb Haemost; 2010 Apr 28; 8(4):808-16. PubMed ID: 20088932
    [Abstract] [Full Text] [Related]

  • 17. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N, Morio Y, Takahashi H, Yamamoto A, Suzuki T, Sato K, Muramatsu M, Fukuchi Y.
    Respiration; 2006 Apr 28; 73(1):105-12. PubMed ID: 16432296
    [Abstract] [Full Text] [Related]

  • 18. [Expression of GATA6 gene in lung tissue of rat with pulmonary hypertension].
    Liu B, Liu HM, Yu L, Sun XJ, Wei L, Wang XM, Zhou TF.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov 28; 37(6):864-7, 875. PubMed ID: 17236581
    [Abstract] [Full Text] [Related]

  • 19. [Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension].
    Tabata T, Ono S, Song C, Noda M, Suzuki S, Tanita T, Fujimura S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Feb 28; 35(2):160-6. PubMed ID: 9103852
    [Abstract] [Full Text] [Related]

  • 20. The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats.
    Prié S, Leung TK, Cernacek P, Ryan JW, Dupuis J.
    J Pharmacol Exp Ther; 1997 Sep 28; 282(3):1312-8. PubMed ID: 9316840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.